MTOR and myelodysplastic syndrome: A study by Jernigan et al. reported a decrease in the expression of mTOR and its downstream components (S6K, eIF4E, and eIF4B) in the postmortem samples of the prefrontal cortex of 12 patients with MDs as compared to healthy controls [217].